Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
Finished Drug Prices
NA
1. (4r,5r)-5-(4-((4-(4-aza-1-azoniabicyclo(2.2.2)octan-1-ylmethyl)phenyl)methoxy)phenyl)-3,3-dibutyl-7-(dimethylamino)-1,1-dioxo-4,5-dihydro-2h-16-benzothiepin-4-ol
2. Livmarli
3. Maralixibat
1. Lopixibat Chloride
2. 228113-66-4
3. Lum-001
4. Maralixibat Chloride [usan]
5. Lum001
6. Maralixibat (chloride)
7. V78m04f0xc
8. 228113-66-4 (chloride)
9. Livmarli
10. Lum 001
11. 4-aza-1-azoniabicyclo(2.2.2)octane, 1-((4-((4-((4r,5r)-3,3-dibutyl-7-(dimethylamino)-2,3,4,5-tetrahydro-4-hydroxy-1,1-dioxido-1-benzothiepin-5-yl)phenoxy)methyl)phenyl)methyl)-, Chloride (1:1)
12. Chembl17879
13. (4r,5r)-5-[4-[[4-(4-aza-1-azoniabicyclo[2.2.2]octan-1-ylmethyl)phenyl]methoxy]phenyl]-3,3-dibutyl-7-(dimethylamino)-1,1-dioxo-4,5-dihydro-2h-1lambda6-benzothiepin-4-ol;chloride
14. 1-(4-((4-((4r,5r)-3,3-dibutyl-7-(dimethylamino)-4-hydroxy-1,1-dioxido-2,3,4,5-tetrahydrobenzo[b]thiepin-5-yl)phenoxy)methyl)benzyl)-1,4-diazabicyclo[2.2.2]octan-1-ium Chloride
15. Lopixibat Chloride [inn]
16. Unii-v78m04f0xc
17. Shp 625
18. Schembl6336189
19. Shp625
20. Maralixibat Chloride (usan/inn)
21. Dtxsid701337104
22. Maralixibat Chloride [inn]
23. Maralixibat Chloride [who-dd]
24. Hy-16747
25. Maralixibat Chloride [orange Book]
26. Cs-0012347
27. D10952
28. Q27291628
Molecular Weight | 710.4 g/mol |
---|---|
Molecular Formula | C40H56ClN3O4S |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 13 |
Exact Mass | 709.3680061 g/mol |
Monoisotopic Mass | 709.3680061 g/mol |
Topological Polar Surface Area | 78.5 Ų |
Heavy Atom Count | 49 |
Formal Charge | 0 |
Complexity | 1080 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Treatment of Progressive Familial Intrahepatic Cholestasis
Treatment of Alagille syndrome
Treatment of biliary atresia
A - Alimentary tract and metabolism
A05 - Bile and liver therapy
A05A - Bile therapy
A05AX - Other drugs for bile therapy
A05AX04 - Maralixibat chloride
Global Sales Information
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
Severity: Warning
Message: include(../assets/text/seoInfo/9831642.txt): Failed to open stream: No such file or directory
Filename: include/seoInfo.php
Line Number: 77
Backtrace:
File: /var/www/html/application/views/include/seoInfo.php
Line: 77
Function: _error_handler
File: /var/www/html/application/views/include/seoInfo.php
Line: 77
Function: include
File: /var/www/html/application/views/include/product/indexNew.php
Line: 1266
Function: include
File: /var/www/html/application/views/commonNew.php
Line: 442
Function: include
File: /var/www/html/application/controllers/Search.php
Line: 1720
Function: view
File: /var/www/html/index.php
Line: 224
Function: require_once
Severity: Warning
Message: include(): Failed opening '../assets/text/seoInfo/9831642.txt' for inclusion (include_path='.:/usr/share/pear:/usr/share/php')
Filename: include/seoInfo.php
Line Number: 77
Backtrace:
File: /var/www/html/application/views/include/seoInfo.php
Line: 77
Function: _error_handler
File: /var/www/html/application/views/include/seoInfo.php
Line: 77
Function: include
File: /var/www/html/application/views/include/product/indexNew.php
Line: 1266
Function: include
File: /var/www/html/application/views/commonNew.php
Line: 442
Function: include
File: /var/www/html/application/controllers/Search.php
Line: 1720
Function: view
File: /var/www/html/index.php
Line: 224
Function: require_once
A Maralixibat Chloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Maralixibat Chloride, including repackagers and relabelers. The FDA regulates Maralixibat Chloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Maralixibat Chloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Maralixibat Chloride supplier is an individual or a company that provides Maralixibat Chloride active pharmaceutical ingredient (API) or Maralixibat Chloride finished formulations upon request. The Maralixibat Chloride suppliers may include Maralixibat Chloride API manufacturers, exporters, distributors and traders.
Maralixibat Chloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Maralixibat Chloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Maralixibat Chloride GMP manufacturer or Maralixibat Chloride GMP API supplier for your needs.
A Maralixibat Chloride CoA (Certificate of Analysis) is a formal document that attests to Maralixibat Chloride's compliance with Maralixibat Chloride specifications and serves as a tool for batch-level quality control.
Maralixibat Chloride CoA mostly includes findings from lab analyses of a specific batch. For each Maralixibat Chloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Maralixibat Chloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Maralixibat Chloride EP), Maralixibat Chloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Maralixibat Chloride USP).
LOOKING FOR A SUPPLIER?